On top of all of its prior problems, troubled French reference lab group Biomnis, now owned by private equity group Ardian, faces the loss of its Lyons premises. The group - which, together with Cerba, is one of the two big traditional French lab chains - is going through a painful restructuring at its Paris and Lyons sites, and is narrowly avoiding bankruptcy at the end of 2012.